XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Research and development expenses (Note 8) $ 1,967 $ 1,810
Marketing expenses (Note 9) 139
General and administrative expenses (Note 10) 2,465 2,091
Total operating expenses 4,432 4,040
Operating loss 4,432 4,040
Other expense 14 53
Financing income, net (11) (26)
Loss for the year 4,435 4,067
Other comprehensive loss (income):    
Foreign currency translation adjustment (23) 21
Comprehensive loss for the year $ 4,412 $ 4,088
Loss per share (Basic and Diluted) $ 0.29 $ 0.26
Weighted average number of common stock outstanding used in computing basic and diluted net loss per share 15,474,660 15,450,824